세포사멸 조절 단백질인 IEX-1의 새로운 결합단백질로서의 CATHEPSIN B의 발견

Identification of CATHEPSIN B as a Novel Binding Protein of the Cell Death Regulating Protein IEX-1

  • 유상미 (중앙대학교 자연과학대학 생명과학과) ;
  • 이강석 (중앙대학교 자연과학대학 생명과학과) ;
  • 배지현 (중앙대학교 약학대학 약학부)
  • Ryou, Sang-Mi (Dept. of Life Science, College of Natural Science, Chung-Ang University) ;
  • Lee, Kang-Seok (Dept. of Life Science, College of Natural Science, Chung-Ang University) ;
  • Bae, Jee-Hyeon (College of Pharmacy, Chung-Ang University)
  • 투고 : 2012.03.23
  • 심사 : 2012.06.20
  • 발행 : 2012.06.30

초록

선행연구에서 본 연구자는 IEX-1 단백질이 난소 암세포에서 세포사멸(apoptosis)을 유도하는 기능을 수행함을 확인하였으나, 세포사멸과 세포생존의 여러 단계에서 어떠한 신호전달 체계로 IEX-1이 작용하는지는 정확히 알지 못하고 있다. 따라서 IEX-1 단백질과 결합하는 새로운 단백질을 찾기 위해 yeast two-hybrid system을 이용하였다. 그 결과 IEX-1이 여러 다양한 인간 암 세포에서 세포사멸을 유도하는 CATHEPSIN B 단백질과 결합함을 밝혔다. 본 연구에서는 리소좀 프로테아제의 일원인 CATHEPSIN B 단백질과 IEX-1 단백질의 결합을 면역침강법과 western blot 분석으로 확인하였다. 그러므로 이 결과들을 통해서 IEX-1과 CATHEPSIN B는 세포 내에서 서로의 기능에 영향을 미칠 것으로 예상되며, 세포사멸을 유도하는 IEX-1 단백질이 lysosome-mediated apoptotic pathway에 관여할 가능성을 시사한다.

Previously, we identified that the overexpression of IEX-1 induces apoptosis in ovarian cancer cells. Herein we report a new binding partner of IEX-1, CATHEPSIN B, as a lysosomal enzyme which contributes to the various apoptotic signaling in tumor cells. To investigate how IEX-1 regulates cellular survival and death event, we performed yeast two-hybrid screening of rat ovarian cDNA library using IEX-1 as the bait and found CATHEPSIN B. In the present study, CATHEPSIN B and IEX-1 proteins were overexpressed in 293T cells and their specific association was determined by immunoprecipitation and immunoblot analysis. In addition, the endogenous interaction between CATHEPSIN B and IEX-1 was confirmed in HeLa cells. The current finding of lysosomal CATHEPSIN B as the IEX-1-binding partner implies that IEX-1 may involve in lysosome-mediated apoptotic signaling pathways.

키워드

참고문헌

  1. Arlt A, Grobe O, Sieke A, Kruse ML, Folsch UR, Schmidt WE, Schafer H (2001). Expression of the NF-kappa B target gene IEX-1 (p22/PRG1) does not prevent cell death but instead triggers apoptosis in Hela cells. Oncogene 20:69-76. https://doi.org/10.1038/sj.onc.1204061
  2. Arlt A, Kruse ML, Breitenbroich M, Gehrz A, Koc B, Minkenberg J, Folsch UR, Schafer H. (2003). The early response gene IEX-1 attenuates NF-kappaB activation in 293 cells, a possible counter-regulatory process leading to enhanced cell death. Oncogene 22: 3343-3351. https://doi.org/10.1038/sj.onc.1206524
  3. Arlt A, Rosenstiel P, Kruse ML, Grohmann F, Minkenberg J, Perkins ND, Folsch UR, Schreiber S, Schafer H (2008). IEX-1 directly interferes with RelA/p65 dependent transactivation and regulation of apoptosis. Biochim Biophys Acta 1783:941-952. https://doi.org/10.1016/j.bbamcr.2007.12.010
  4. Barrett AJ (1994). The possible role of neutrophil proteinases in damage to articular cartilage. 1978. Agents Actions 43:194-200; discussion 200-1. https://doi.org/10.1007/BF01986688
  5. Charles CH, Yoon JK, Simske JS, Lau LF (1993). Genomic structure, cDNA sequence, and expression of gly96, a growth factor-inducible immediate-early gene encoding a short-lived glycosylated protein. Oncogene 8:797-801.
  6. Felbor U, Dreier L, Bryant RA, Ploegh HL, Olsen BR, Mothes W (2000). Secreted cathepsin L generates endostatin from collagen XVIII. Embo J 19:1187-1194. https://doi.org/10.1093/emboj/19.6.1187
  7. Garcia J, Ye Y, Arranz V, Letourneux C, Pezeron G, Porteu F (2002). IEX-1: a new ERK substrate involved in both ERK survival activity and ERK activation. Embo J 21:5151-5163. https://doi.org/10.1093/emboj/cdf488
  8. Green DR, Reed JC (1998). Mitochondria and apoptosis. Science 281:1309-1312. https://doi.org/10.1126/science.281.5381.1309
  9. Im HJ, Craig TA, Pittelkow MR, Kumar R (2002). Characterization of a novel hexameric repeat DNA sequence in the promoter of the immediate early gene, IEX-1, that mediates 1alpha,25-dihydroxyvitamin D(3)- associated IEX-1 gene repression. Oncogene 21:3706-3714. https://doi.org/10.1038/sj.onc.1205450
  10. Kim JH, Lee KA, Bae J (2011) BCL2L10 protein induces apoptosis in KGN-human granulosa cells. Develpoment and Reproduction 15:113-120.
  11. Kobayashi T, Pittelkow MR, Warner GM, Squillace KA, Kumar R (1998). Regulation of a novel immediate early response gene, IEX-1, in keratinocytes by 1alpha, 25-dihydroxyvitamin D3. Biochem Biophys Res Commun 251:868-873. https://doi.org/10.1006/bbrc.1998.9556
  12. Koblinski JE, Ahram M, Sloane BF (2000). Unraveling the role of proteases in cancer. Clin Chim Acta 291:113-135. https://doi.org/10.1016/S0009-8981(99)00224-7
  13. Kruse ML, Arlt A, Sieke A, Grohmann F, Grossmann M, Minkenberg J, Folsch UR, Schafer H (2005). Immediate early gene X1 (IEX-1) is organized in subnuclear structures and partially co-localizes with promyelocytic leukemia protein in HeLa cells. J Biol Chem 280: 24849-24856. https://doi.org/10.1074/jbc.M501571200
  14. Kumar R, Lutz W, Frank E, Im HJ (2004). Immediate early gene X-1 interacts with proteins that modulate apoptosis. Biochem Biophys Res Commun 323:1293-1298. https://doi.org/10.1016/j.bbrc.2004.09.006
  15. Li W, Yuan XM, Ivanova S, Tracey KJ, Eaton JW, Brunk UT (2003). 3-Aminopropanal, formed during cerebral ischaemia, is a potent lysosomotropic neurotoxin. Biochem J 371:429-436. https://doi.org/10.1042/BJ20021520
  16. Li W, Yuan X, Nordgren G, Dalen H, Dubowchik GM, Firestone RA, Brunk UT (2000). Induction of cell death by the lysosomotropic detergent MSDH. FEBS Lett 470:35-39. https://doi.org/10.1016/S0014-5793(00)01286-2
  17. Manna SK, Zhang HJ, Yan T, Oberley LW, Aggarwal BB (1998). Overexpression of manganese superoxide dismutase suppresses tumor necrosis factor-induced apoptosis and activation of nuclear transcription factorkappaB and activated protein-1. J Biol Chem 273:13245-13254. https://doi.org/10.1074/jbc.273.21.13245
  18. Osawa Y, Nagaki M, Banno Y, Brenner DA, Nozawa Y, Moriwaki H, Nakashima S (2003). Expression of the NF-kappa B target gene X-ray-inducible immediate early response factor-1 short enhances TNF-alphainduced hepatocyte apoptosis by inhibiting Akt activation. J Immunol 170:4053-4060. https://doi.org/10.4049/jimmunol.170.8.4053
  19. Schilling D, Pittelkow MR, Kumar R (2001). IEX-1, an immediate early gene, increases the rate of apoptosis in keratinocytes. Oncogene 20:7992-7997. https://doi.org/10.1038/sj.onc.1204965
  20. Shen L, Guo J, Santos-Berrios C, Wu MX (2006). Distinct domains for anti- and pro-apoptotic activities of IEX-1. J Biol Chem 281:15304-15311. https://doi.org/10.1074/jbc.M600054200
  21. Stoka V, Turk B, Schendel SL, Kim TH, Cirman T, Snipas SJ, Ellerby LM, Bredesen D, Freeze H, Abrahamson M, Bromme D, Krajewski S, Reed JC, Yin XM, Turk V, Salvesen GS (2001). Lysosomal protease pathways to apoptosis. Cleavage of bid, not pro-caspases, is the most likely route. J Biol Chem 276:3149-3157. https://doi.org/10.1074/jbc.M008944200
  22. Tait DL, Obermiller PS, Hatmaker AR, Redlin-Frazier S, Holt JT (1999). Ovarian cancer BRCA1 gene therapy: Phase I and II trial differences in immune response and vector stability. Clin Cancer Res 5:1708-1714.
  23. Turk B, Stoka V, Rozman-Pungercar J, Cirman T, Droga- Mazovec G, Oresic K, Turk V (2002). Apoptotic pathways: involvement of lysosomal proteases. Biol Chem 383:1035-1044.
  24. Vancompernolle K, Van Herreweghe F, Pynaert G, Van de Craen M, De Vos K, Totty N, Sterling A, Fiers W, Vandenabeele P, Grooten J (1998). Atractyloside-induced release of cathepsin B, a protease with caspase-processing activity. FEBS Lett 438:150-158. https://doi.org/10.1016/S0014-5793(98)01275-7
  25. Yoon S, Ha HJ, Kim YH, Won M, Park M, Ko JJ, Lee K, Bae J (2009). IEX-1-induced cell death requires BIM and is modulated by MCL-1. Biochem Biophys Res Commun 382:400-404. https://doi.org/10.1016/j.bbrc.2009.03.037
  26. Yoon S, Na SY, Kim HM, Lee K, Bae J (2010) Mutural activities of IEX-1 and MCL-1 on the apoptosis of ovarian cancer cells. Develpoment and Reproduction 14:83-89.
  27. Zhang Y, Finegold MJ, Porteu F, Kanteti P, Wu MX (2003). Development of T-cell lymphomas in Emu-IEX-1 mice. Oncogene 22:6845-6851. https://doi.org/10.1038/sj.onc.1206707